Copy Link Print Information

Doramapimod

(Synonyms: BIRB 796)
52 Cited Publications
Revisión del cliente

Based on 52 publication(s) in Google Scholar

Doramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38α=38 nM, for p38β=65 nM, for p38γ=200 nM, and for p38δ=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0.1 nM). Doramapimod also inhibits B-Raf with an IC50 of 83 nM.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.93%
  • No. CAS: 285983-48-4
  • Fòrmula: C31H37N5O3
  • Peso molecular:527.66
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 1 year , -20°C, 6 months
  • Doramapimod Chemical Structure
    Doramapimod Chemical Structure
  • Experimental Validation Results for Doramapimod
  • Experimental Validation Results for Doramapimod
  • Experimental Validation Results for Doramapimod
  • Experimental Validation Results for Doramapimod
  • Experimental Validation Results for Doramapimod
No. CAS: 285983-48-4
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Doramapimod:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Doramapimod

More
Customer Validation & Images
IP2D/3D Cell Culture and DifferentiationWBIF
  • WB
  • WB
  • IF
  • 2D/3D Cell Culture and Differentiation
  • IP

Ver todos los productos específicos de isoformas p38 MAPK

More

Ver todos los productos específicos de isoformas Raf

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Doramapimod Chemical Structure
    Doramapimod Chemical Structure
    1/16
  • 1/16

    Doramapimod purchased from MedChemExpress. Usage Cited in: Engineering. 2025 Mar 4.

    Customer Validation
     BIRB 796 (10 μM, 36 h) inhibited the expression of p-p38 MAPK induced by LPS (200 ng/mL) in THP-1 cells.

  • 1/16

    Doramapimod purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Sep 6:76:103344. [Abstract]

    Customer Validation
     BIRB 796 (DORA, 10 μM, 4 h) inhibited the expression of p-p38 MAPK induced by LPS (1000 ng/mL) in 10T1/2 cells.

  • 1/16

    Doramapimod purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Sep 6:76:103344. [Abstract]

    Customer Validation
     BIRB 796 (DORA, 10 μM, 4 h) inhibited the mitochondrial recruitment of DRP1 and the fission induced by LPS (1000 ng/mL) in 10T1/2 cells.

  • 1/16

    Doramapimod purchased from MedChemExpress. Usage Cited in: Cell Res. 2020 Jul;30(7):574-589. [Abstract]

    Customer Validation
     Birb 796 (0.1, 0.3, 1, and 3 μM, 3 days) impaired the ability of SSK1 (0.5 μM,3 days) to specifically kill senescent HUVEC.

  • 1/16

    Doramapimod purchased from MedChemExpress. Usage Cited in: Nature. 2019 Jul;571(7763):127-131. [Abstract]

    Customer Validation
     BIRB 796 (1 μM, 4.5 h) did not abrogate EGF-induced pUGDH in A549 cells stably expressing Flag–UGDH.

  • Doramapimod